Auf dieser Seite
ETON Eton Pharmaceuticals, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 13, 2026
$55,36
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$14,4952-Wochen-Tief
$66,3752-Wochen-Hoch
Marktkapitalisierung (MRQ)
$1.57B
Umsatz
$80M
Ihre Abzeichen
52W-Spanne
$14–$66
Analystenbewertung
BUY
Kursziel
$71
P/E
·
ROE
-18.4%
Nettogewinnmarge
12.0%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
ETON Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$55.36
Marktkapitalisierung (MRQ)
$1.57B
Umsatz
$80M
ROE
-18.4%
Verschuldungsgrad (MRQ)
0.4
52W-Spanne
$14–$66
ETON Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$80M2019-12-31 → 2025-12-31
Freier Cashflow$10M2018-12-31 → 2025-12-31
Nettogewinnmarge12.0%2020-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | ETON | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/S (TTM) | 14.85-Jahres-Durchschnitt ≈5.8 | ≈5.8 | 4.1 | Überbewertet | |
| K/B (MRQ) | 33.65-Jahres-Durchschnitt ≈10.9 | ≈10.9 | 3.6 | Überbewertet | |
| EV / EBITDA | -1779.65-Jahres-Durchschnitt ≈-188.7 | ≈-188.7 | · | · | |
| Kurs / FCF (TTM) | 106.35-Jahres-Durchschnitt ≈103.7 | ≈103.7 | · | · | |
| Kurs / Cashflow (TTM) | 103.55-Jahres-Durchschnitt ≈100.8 | ≈100.8 | 11.3 | Überbewertet | |
| EV / Revenue (EV / Umsatz) | 18.85-Jahres-Durchschnitt ≈5.4 | ≈5.4 | · | · | |
| EV / FCF | 147.45-Jahres-Durchschnitt ≈99.7 | ≈99.7 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 1726.75-Jahres-Durchschnitt ≈8.9 | ≈8.9 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | ETON | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Bruttogewinnmarge (TTM) | 57.9%5-Jahres-Durchschnitt ≈67.2% | ≈67.2% | · | · | |
| Betriebsgewinnmarge (TTM) | 15.4%5-Jahres-Durchschnitt ≈-13.4% | ≈-13.4% | 12.8% | Spitzenklasse | |
| EBITDA Margin (EBITDA-Marge) | -1.1%5-Jahres-Durchschnitt ≈-13.1% | ≈-13.1% | 10.4% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | 12.1%5-Jahres-Durchschnitt ≈-16.7% | ≈-16.7% | 9.0% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | 12.0%5-Jahres-Durchschnitt ≈-16.7% | ≈-16.7% | -13.6% | Spitzenklasse | |
| ROA | -5.5%5-Jahres-Durchschnitt ≈-13.6% | ≈-13.6% | 0.16% | Schwach | |
| ROE | -18.4%5-Jahres-Durchschnitt ≈-30.9% | ≈-30.9% | -12.9% | Schwach | |
| ROIC | -1.5% | · | 9.5% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | ETON | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 0.45-Jahres-Durchschnitt ≈0.3 | ≈0.3 | 0.5 | Im Einklang | |
| Liquiditätsgrad (MRQ) | 1.55-Jahres-Durchschnitt ≈3.0 | ≈3.0 | 3.0 | Geringe Liquidität | |
| Quick Ratio | 1.05-Jahres-Durchschnitt ≈2.3 | ≈2.3 | 2.2 | Geringe Liquidität | |
| Langfristige Schulden / Eigenkapital (MRQ) | 0.4 | · | 0.4 | Im Einklang |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | ETON | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 104.9%5-Jahres-Durchschnitt ≈11210.8% | ≈11210.8% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 55.5%5-Jahres-Durchschnitt ≈303.2% | ≈303.2% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 359.6% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | ETON | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 1.05-Jahres-Durchschnitt ≈0.8 | ≈0.8 | 0.7 | Spitzenklasse | |
| Inventory Turnover (Lagerumschlag) | 2.45-Jahres-Durchschnitt ≈5.6 | ≈5.6 | · | · | |
| Receivables Turnover (Forderungsumschlag) | 9.35-Jahres-Durchschnitt ≈8.0 | ≈8.0 | 6.4 | Spitzenklasse | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$1.8M | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-28.1%
Nächster Bericht
Nov 09, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 13, 2026 | $0.35 | $0.11 | 226.8% |
| 31. März 2026 | Mai 14, 2026 | $0.05 | $0.09 | -45.5% |
| 31. Dezember 2025 | $0.06 | $0.09 | -34.6% | |
| 30. September 2025 | $-0.07 | $0.09 | -176.3% | |
| 30. Juni 2025 | $-0.10 | $-0.04 | -167.4% | |
| 31. März 2025 | $0.07 | $0.05 | 28.7% | |
| 31. Dezember 2024 | $-0.02 | $-0.00 | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $80M | $39M | $32M | $21M | $22M | $39.0K | $959.0K | |
| Cost of Revenue | $37M | $16M | $11M | $7M | $3M | $436.0K | $453.0K | |
| Gross Profit | $43M | $23M | $21M | $14M | $19M | $-397.0K | $506.0K | |
| R&D Expense | $8M | $3M | $3M | $4M | $6M | $14M | $12M | |
| SG&A Expense | $36M | $23M | $19M | $19M | $14M | $13M | $8M | |
| Operating Expenses | $44M | $26M | $22M | $23M | $20M | $27M | $19M | |
| Operating Income | $-844.0K | $-3M | $-1M | $-8M | $-1M | $-27M | $-19M | |
| Interest Expense | · | · | $1M | $955.0K | $1M | $884.0K | $98.0K | |
| Other Non-op | $-4M | $-1M | $503.0K | $-761.0K | $-1M | $-859.0K | $281.0K | |
| Pretax Income | $-5M | $-4M | $-689.0K | $-9M | $-2M | $-28M | $-18M | |
| Income Tax | $43.0K | $15.0K | $247.0K | $0 | $0 | · | · | |
| Net Income | $-5M | $-4M | $-936.0K | $-9M | $-2M | $-28M | $-18M | |
| EPS (Basic) | $-0.17 | $-0.15 | $-0.04 | $-0.36 | $-0.08 | $-1.33 | · | |
| Shares (Basic) | 26,908,000 | 25,895,000 | 25,645,000 | 25,146,000 | 25,207,000 | 21,010,000 | · | |
| EBITDA | $-844.0K | $-3M | · | $-8M | $-1M | $-27M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $26M | $15M | $21M | $16M | $14M | $21M | $12M | |
| Receivables | $12M | $5M | $3M | $2M | $5M | $48.0K | $473.0K | |
| Inventory | $15M | $15M | $911.0K | $557.0K | $550.0K | $1M | $380.0K | |
| Prepaid Expense | $7M | $5M | $1M | $1M | $3M | $2M | $2M | |
| Current Assets | $61M | $41M | $27M | $20M | $24M | $25M | $15M | |
| PP&E (Net) | $326.0K | $34.0K | $58.0K | $72.0K | $115.0K | $811.0K | $1M | |
| PP&E (Gross) | $812.0K | $480.0K | $453.0K | $424.0K | $466.0K | $2M | $1M | |
| Accum. Depreciation | $486.0K | $446.0K | $395.0K | $352.0K | $351.0K | $692.0K | $345.0K | |
| Intangibles | $31M | $35M | $5M | $5M | $4M | $575.0K | $725.0K | |
| Other Non-current Assets | $19.0K | $12.0K | $12.0K | $12.0K | $21.0K | $40.0K | $61.0K | |
| Total Assets | $92M | $76M | $32M | $25M | $27M | $26M | $17M | |
| Accounts Payable | $11M | $4M | $2M | $2M | $2M | $2M | $575.0K | |
| Accrued Liabilities | $9M | $9M | $5M | $4M | $1M | $1M | $1M | |
| Current Liabilities | $38M | $20M | $16M | $6M | $5M | $4M | $2M | |
| Capital Leases | $460.0K | $107.0K | $22.0K | $107.0K | $15.0K | $99.0K | $19.0K | |
| Other Non-current Liabilities | $5M | $2M | $0 | · | · | · | · | |
| Total Liabilities | $66M | $52M | $16M | $12M | $10M | $11M | $7M | |
| Long-term Debt | $31M | $30M | $0 | $5M | $5M | $7M | $5M | |
| Total Debt | $31M | $0 | · | $1M | $1M | · | · | |
| Common Stock | $27.0K | $27.0K | $26.0K | $25.0K | $25.0K | $24.0K | $18.0K | |
| Paid-in Capital | · | $132M | · | · | · | · | $75M | |
| Retained Earnings | $-112M | $-108M | $-104M | $-103M | $-94M | $-92M | $-64M | |
| Stockholders' Equity | $26M | $24M | $15M | $13M | $18M | $18M | $11M | |
| Liabilities + Equity | $92M | $76M | $32M | $25M | $27M | $26M | $17M | |
| Shares Outstanding | 27,047,061 | 26,709,084 | 25,688,062 | 25,353,119 | 24,626,004 | 24,312,808 | 17,877,486 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $1M | $901.0K | $66.0K | $155.0K | $347.0K | $283.0K | |
| Stock-based Comp | $6M | $3M | $3M | $4M | $3M | $3M | $2M | |
| Amort. of Intangibles | $4M | $1M | $790.0K | $2M | $204.0K | $150.0K | $25.0K | |
| Other Non-cash | · | · | · | $10M | $-6M | · | · | |
| Operating Cash Flow | $11M | $969.0K | $7M | $5M | $-5M | $-22M | $-18M | |
| CapEx | $333.0K | $26.0K | $0 | $38.0K | $9.0K | $50.0K | $1M | |
| Investing Cash Flow | $-333.0K | $-40M | $-775.0K | $-3M | $-3M | $-50.0K | $-2M | |
| Debt Issued | $0 | $25M | $0 | $0 | · | $2M | $5M | |
| Net Debt Issued | $0 | $24M | · | · | · | $2M | · | |
| Stock Issued | · | · | · | · | · | $29M | · | |
| Net Stock Activity | · | · | · | · | · | $29M | · | |
| Financing Cash Flow | $815.0K | $33M | $-957.0K | $-134.0K | $391.0K | $32M | $5M | |
| Net Change in Cash | $11M | $-6M | $5M | $2M | $-7M | $9M | $-15M | |
| Taxes Paid | $118.0K | $82.0K | $247.0K | $0 | $0 | · | · | |
| Free Cash Flow | $10M | $943.0K | · | $5M | $-5M | $-22M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 53.5% | 60.0% | · | 67.4% | 88.0% | -633.3% | · | |
| Operating Margin | -1.1% | -6.7% | · | -38.9% | -6.9% | -69515.4% | · | |
| Net Margin | -5.8% | -9.8% | · | -42.4% | -8.9% | -71717.9% | · | |
| Pretax Margin | -5.7% | -9.8% | · | -42.4% | -8.9% | -71717.9% | · | |
| EBITDA Margin | -1.1% | -6.7% | · | -38.6% | -6.1% | -69515.4% | · | |
| ROA | -5.5% | -7.1% | · | -34.4% | -7.3% | -128.9% | · | |
| ROE | -18.4% | -18.9% | · | -74.4% | -11.8% | -328.1% | · | |
| ROIC | -1.5% | -10.7% | · | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 2.1 | · | 3.1 | 5.2 | 6.5 | · | |
| Quick Ratio | 1.0 | 1.0 | · | 2.8 | 4.4 | 5.6 | · | |
| Debt / Equity | 1.2 | 0.0 | · | 0.1 | 0.1 | · | · | |
| LT Debt / Equity | 0.8 | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | -8.6 | -1.4 | -30.7 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 0.7 | · | 0.8 | 0.8 | 0.0 | · | |
| Inventory Turnover | 2.4 | 1.9 | · | 12.5 | · | 0.4 | · | |
| Receivables Turnover | 9.3 | 8.9 | · | 5.8 | 7.9 | 0.1 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.97 | $0.91 | · | $0.52 | $0.72 | $0.64 | · | |
| Cash / Share | $0.96 | $0.56 | · | $0.64 | $0.58 | $0.88 | · | |
| EPS (TTM) | · | $-0.15 | $-0.06 | $-0.63 | · | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 104.9% | 23.3% | 48.9% | -2.7% | 55879.5% | · | · | |
| Revenue CAGR 3Y | 55.5% | 21.3% | 832.7% | · | · | · | · | |
| Revenue CAGR 5Y | 359.6% | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $80M | $39M | $32M | $21M | $22M | $39.0K | $959.0K | |
| Net Income TTM | $-5M | $-4M | $-936.0K | $-9M | $-2M | $-28M | $-18M | |
| Market Cap | $457M | $356M | · | $71M | $106M | $198M | · | |
| Enterprise Value | $462M | $341M | · | $56M | $93M | · | · | |
| P/E | · | -88.8 | -73.0 | -4.5 | · | · | · | |
| P/S | 5.7 | 9.1 | · | 3.4 | 4.8 | 5068.3 | · | |
| P/B | 17.5 | 14.6 | · | 5.5 | 6.0 | 12.6 | · | |
| P / Tangible Book | · | · | 10.5 | 8.6 | 7.5 | 11.6 | · | |
| P / Cash Flow | 43.5 | 367.1 | · | 14.8 | -22.4 | -8.8 | · | |
| P / FCF | 44.9 | 377.3 | · | 14.9 | -22.3 | -8.8 | · | |
| EV / EBITDA | -547.4 | -131.2 | · | -6.9 | -69.1 | · | · | |
| EV / FCF | 45.3 | 361.4 | · | 11.8 | -19.6 | · | · | |
| EV / Revenue | 5.8 | 8.7 | · | 2.6 | 4.2 | · | · | |
| Earnings Yield | · | -1.1% | -1.4% | -22.3% | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $38M | $24M | $21M | $22M | $19M | $17M | $12M | $10M | $9M | $8M | $7M | $7M | $12M | $5M | $8M | $3M | |
| Cost of Revenue | $12M | $10M | $8M | $15M | $7M | $7M | $5M | $4M | $3M | $3M | $4M | $3M | $2M | $2M | $2M | $1M | |
| Gross Profit | $25M | $15M | $13M | $8M | $12M | $10M | $6M | $6M | $6M | $5M | $4M | $4M | $10M | $3M | $6M | $2M | |
| R&D Expense | $993.0K | $2M | $2M | $1M | $4M | $1M | $-871.0K | $505.0K | $3M | $651.0K | $1M | $615.0K | $1M | $535.0K | $944.0K | $744.0K | |
| SG&A Expense | $12M | $10M | $9M | $8M | $10M | $9M | $7M | $5M | $6M | $5M | $5M | $4M | $5M | $5M | $4M | $4M | |
| Operating Expenses | $13M | $12M | $11M | $9M | $13M | $10M | $6M | $6M | $9M | $6M | $6M | $5M | $6M | $6M | $5M | $5M | |
| Operating Income | $13M | $2M | $2M | $-1M | $-1M | $-470.0K | $629.0K | $509.0K | $-3M | $-800.0K | $-2M | $-548.0K | $4M | $-3M | $1M | $-3M | |
| Interest Expense | $1M | $1M | · | $1M | $1M | $1M | · | $211.0K | $222.0K | $238.0K | · | $267.0K | $273.0K | $265.0K | · | $233.0K | |
| Other Non-op | · | · | · | · | · | · | $-1M | $-8.0K | $-52.0K | $-11.0K | $-16.0K | $-31.0K | $676.0K | $-126.0K | $-150.0K | $-150.0K | |
| Pretax Income | $12M | $2M | $1M | $-2M | $-3M | $-1M | $-511.0K | $501.0K | $-3M | $-811.0K | $-2M | $-579.0K | $5M | $-3M | $912.0K | $-3M | |
| Income Tax | $140.0K | $20.0K | $-69.0K | $-28.0K | $66.0K | $74.0K | $87.0K | $-126.0K | $54.0K | $0 | $247.0K | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $12M | $2M | $1M | $-2M | $-3M | $-2M | $-598.0K | $627.0K | $-3M | $-811.0K | $-2M | $-579.0K | $5M | $-3M | $912.0K | $-3M | |
| EPS (Basic) | $0.42 | $0.06 | $0.06 | $-0.07 | $-0.10 | $-0.06 | $-0.02 | $0.02 | $-0.12 | $-0.03 | $-0.10 | $-0.02 | $0.18 | $-0.10 | $209.82 | $-0.12 | |
| EPS (Diluted) | $0.35 | $0.05 | · | $-0.07 | $-0.10 | $-0.06 | · | $0.02 | $-0.12 | $-0.03 | · | $-0.02 | $0.18 | $-0.10 | · | $-0.12 | |
| Shares (Basic) | 27,642,000 | 27,285,000 | · | 26,893,000 | 26,893,000 | 26,886,000 | · | 25,900,000 | 25,778,000 | 25,763,000 | · | 25,719 | 25,593 | 25,525 | · | 25,365,000 | |
| Shares (Diluted) | 32,787,000 | 31,547,000 | · | 26,893,000 | 26,893,000 | 26,886,000 | · | 26,550,000 | 25,778 | 25,763 | · | 25,719 | 25,983 | 25,525 | · | 25,365,000 | |
| EBITDA | $13M | $2M | · | $-1M | $-1M | $-470.0K | · | $509.0K | $-3M | $-800.0K | · | $-548.0K | $4M | $-3M | · | $-3M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $27M | $20M | $26M | $37M | $25M | $17M | $15M | $20M | $18M | $17M | · | $22M | $22M | $15M | · | $13M | |
| Receivables | $25M | $13M | $12M | $13M | $14M | $16M | $5M | $6M | $5M | $4M | · | $3M | $3M | $3M | · | $1M | |
| Inventory | $10M | $14M | $15M | $17M | $24M | $14M | $15M | $2M | $2M | $2M | · | $1M | $816.0K | $437.0K | · | $481.0K | |
| Prepaid Expense | $7M | $6M | $7M | $5M | $5M | $3M | $5M | $2M | $799.0K | $1M | · | $541.0K | $867.0K | $1M | · | $1M | |
| Current Assets | $69M | $53M | $61M | $72M | $68M | $50M | $41M | $30M | $25M | $24M | · | $27M | $26M | $19M | · | $16M | |
| PP&E (Net) | $352.0K | $372.0K | $326.0K | $294.0K | $18.0K | $22.0K | $34.0K | $33.0K | $45.0K | $57.0K | · | $38.0K | $46.0K | $56.0K | · | $73.0K | |
| PP&E (Gross) | $466.0K | $880.0K | $812.0K | · | · | · | $480.0K | $467.0K | $467.0K | $467.0K | · | $421.0K | $421.0K | $421.0K | · | $412.0K | |
| Accum. Depreciation | $114.0K | $508.0K | $486.0K | · | · | · | $446.0K | $434.0K | $422.0K | $410.0K | · | $383.0K | $375.0K | $365.0K | · | $339.0K | |
| Intangibles | $46M | $44M | $31M | $32M | $33M | $34M | $35M | $6M | $6M | $6M | · | $4M | $4M | $5M | · | $5M | |
| Other Non-current Assets | $64.0K | $54.0K | $19.0K | $19.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | · | $12.0K | $12.0K | $12.0K | · | $12.0K | |
| Total Assets | $116M | $98M | $92M | $105M | $102M | $84M | $76M | $36M | $32M | $31M | · | $32M | $31M | $24M | · | $22M | |
| Accounts Payable | $14M | $13M | $11M | $14M | $12M | $5M | $4M | $3M | $2M | $2M | · | $2M | $2M | $1M | · | $1M | |
| Accrued Liabilities | $11M | $8M | $9M | $9M | $7M | $8M | $9M | · | $11M | $8M | · | $7M | $6M | $5M | · | $3M | |
| Current Liabilities | $45M | $44M | $38M | $44M | $39M | $25M | $20M | $20M | $18M | $15M | · | $10M | $10M | $7M | · | $5M | |
| Capital Leases | $1M | $440.0K | $460.0K | $480.0K | $492.0K | $87.0K | $107.0K | $126.0K | $145.0K | $0 | · | $44.0K | $66.0K | $86.0K | · | · | |
| Other Non-current Liabilities | $4M | $4M | $5M | $4M | $4M | $4M | $2M | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $69M | $67M | $66M | $81M | $78M | $60M | $52M | $20M | $18M | $15M | · | $15M | $14M | $13M | · | $10M | |
| Long-term Debt | · | · | $31M | · | · | $30M | $30M | · | · | · | · | $4M | $5M | $5M | · | $6M | |
| Total Debt | $19M | $19M | · | $28M | $27M | · | · | $4M | $5M | $5M | · | $2M | $2M | $1M | · | $708.0K | |
| Common Stock | $28.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $26.0K | $26.0K | $26.0K | · | $26.0K | $26.0K | $26.0K | · | $25.0K | |
| Paid-in Capital | · | · | · | $137M | $136M | · | · | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-99M | $-111M | $-112M | $-114M | $-112M | $-109M | $-108M | $-107M | $-108M | $-105M | · | $-102M | $-101M | $-106M | · | $-104M | |
| Stockholders' Equity | $47M | $31M | $26M | $23M | $24M | $24M | $24M | $16M | $13M | $15M | $15M | $17M | $17M | $11M | $13M | $11M | |
| Liabilities + Equity | $116M | $98M | $92M | $105M | $102M | $84M | $76M | $36M | $32M | $31M | · | $32M | $31M | $24M | · | $22M | |
| Shares Outstanding | 28,289,941 | 27,359,791 | 27,047,061 | 26,817,535 | 26,817,535 | 26,817,535 | 26,709,084 | 25,836,204 | 25,745,802 | 25,690,562 | 25,688,062 | 25,658,396 | 25,561,994 | 25,504,378 | 25,353,119 | 25,297,037 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $1M | $1M | $1M | $355.0K | $278.0K | $261.0K | $234.0K | $325.0K | $152.0K | $172.0K | $213.0K | $252.0K | $14.0K | |
| Stock-based Comp | $1M | $2M | $1M | $1M | $2M | $1M | $782.0K | $722.0K | $840.0K | $821.0K | $750.0K | $730.0K | $785.0K | $872.0K | $886.0K | $949.0K | |
| Amort. of Intangibles | $1M | $1M | $1M | $1M | $1M | $1M | $342.0K | $267.0K | $267.0K | $220.0K | $246.0K | $182.0K | $181.0K | $181.0K | $1M | $135.0K | |
| Operating Cash Flow | $7M | $7M | $-12M | $12M | $8M | $2M | $-765.0K | $3M | $1M | $-2M | $387.0K | $873.0K | $7M | $-2M | $3M | $-2M | |
| CapEx | $-5.0K | $75.0K | $49.0K | $284.0K | $0 | $0 | $12.0K | $0 | $0 | $14.0K | $0 | $0 | $0 | $0 | $12.0K | $0 | |
| Investing Cash Flow | $5.0K | $-15M | $-49.0K | $-284.0K | $0 | $0 | $-38M | $0 | $0 | $-2M | $-775.0K | $0 | $0 | $0 | $-12.0K | $-2M | |
| Net Debt Issued | · | · | · | · | · | $0 | · | · | · | $-385.0K | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-76.0K | $1M | $421.0K | $0 | $0 | $394.0K | $34M | $-385.0K | $-216.0K | $-378.0K | $-294.0K | $-368.0K | $-245.0K | $-49.0K | $99.0K | $35.0K | |
| Net Change in Cash | $7M | $-6M | $-11M | $12M | $8M | $2M | $-5M | $3M | $1M | $-5M | $-682.0K | $504.0K | $7M | $-2M | $3M | $-4M | |
| Taxes Paid | $48.0K | $37.0K | $1.0K | $28.0K | $81.0K | $8.0K | $-99.0K | $181.0K | $0 | $0 | $247.0K | $0 | $0 | $0 | $0 | $0 | |
| Free Cash Flow | · | $7M | · | · | · | $2M | · | · | · | $-2M | · | · | · | $-2M | · | · | |
| Levered FCF | · | $6M | · | · | · | $869.5K | · | · | · | $-3M | · | · | · | $-2M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.6% | 60.7% | · | 35.0% | 63.0% | 57.1% | · | 61.0% | 62.0% | 62.8% | · | 62.6% | 80.7% | 63.1% | · | 62.7% | |
| Operating Margin | 34.0% | 10.0% | · | -6.1% | -7.8% | -2.7% | · | 4.9% | -32.4% | -10.0% | · | -7.8% | 32.4% | -47.8% | · | -89.9% | |
| Net Margin | 30.8% | 6.4% | · | -8.6% | -13.7% | -9.1% | · | 6.1% | -33.5% | -10.2% | · | -8.2% | 38.0% | -50.1% | · | -94.6% | |
| Pretax Margin | 31.2% | 6.5% | · | -8.7% | -13.3% | -8.7% | · | 4.9% | -32.9% | -10.2% | · | -8.2% | 38.0% | -50.1% | · | -94.6% | |
| EBITDA Margin | 34.0% | 10.0% | · | -6.1% | -7.8% | -2.7% | · | 4.9% | -32.4% | -10.0% | · | -7.8% | 32.4% | -47.8% | · | -89.5% | |
| ROA | 10.7% | 1.7% | · | -2.8% | -3.9% | -2.7% | · | 1.9% | -9.7% | -3.0% | · | -2.2% | 16.9% | -11.3% | · | -12.7% | |
| ROE | 32.8% | 5.6% | · | -9.9% | -13.8% | -7.9% | · | 3.8% | -20.2% | -6.1% | · | -4.1% | 30.4% | -21.6% | · | -22.7% | |
| ROIC | 19.2% | 4.8% | · | -2.6% | -2.9% | -2.0% | · | 3.2% | -16.5% | -3.9% | · | -3.0% | 21.3% | -20.1% | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.2 | · | 1.6 | 1.8 | 2.0 | · | 1.5 | 1.4 | 1.6 | · | 2.6 | 2.7 | 2.6 | · | 3.5 | |
| Quick Ratio | 1.1 | 0.7 | · | 1.1 | 1.0 | 1.3 | · | 1.3 | 1.2 | 1.4 | · | 2.5 | 2.6 | 2.3 | · | 3.2 | |
| Debt / Equity | 0.4 | 0.6 | · | 1.2 | 1.1 | · | · | 0.3 | 0.3 | 0.3 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| LT Debt / Equity | 0.4 | 0.6 | · | 1.2 | 1.1 | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | 2.1 | · | -1.1 | · | -0.4 | · | 2.4 | · | -3.4 | · | -0.7 | · | -9.6 | · | · |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.4 | 0.2 | · | 0.1 | |
| Inventory Turnover | 0.7 | 0.7 | · | 1.6 | 0.5 | 0.9 | · | 2.7 | 2.4 | 2.1 | · | 3.4 | 3.4 | 4.1 | · | 2.9 | |
| Receivables Turnover | 1.9 | 1.6 | · | 2.4 | 2.0 | 1.7 | · | 2.3 | 2.3 | 2.2 | · | 2.8 | 6.1 | 2.9 | · | 3.4 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.65 | $1.12 | · | $0.86 | $0.89 | $0.91 | · | $0.62 | $0.52 | $0.60 | · | $0.66 | $0.65 | $0.44 | · | $0.44 | |
| Revenue / Share | $1.15 | $0.77 | · | $0.84 | · | · | · | $388.85 | $352.01 | $309.20 | · | $0.27 | $0.46 | · | · | $0.13 | |
| Cash Flow / Share | · | $0.23 | · | · | · | · | · | · | · | $-95.99 | · | · | · | · | · | · | |
| Cash / Share | $0.95 | $0.72 | · | $1.38 | $0.95 | $0.65 | · | $0.78 | $0.69 | $0.65 | · | $0.86 | $0.84 | $0.58 | · | $0.53 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $106M | $87M | · | $70M | $58M | $48M | · | $35M | $31M | $34M | · | $33M | $29M | $24M | · | $19M | |
| Net Income TTM | $13M | $-1M | · | $-7M | $-4M | $-5M | · | $-5M | $-7M | $913.0K | · | $2M | $-234.0K | $-6M | · | $-9M | |
| Market Cap | $1.02B | $675M | · | $583M | $382M | $348M | · | $155M | $85M | $96M | · | $107M | $89M | $98M | · | $53M | |
| Enterprise Value | $1.02B | $675M | · | $573M | $384M | · | · | $139M | $72M | $85M | · | $86M | $69M | $85M | · | $40M | |
| P/S | 9.7 | 7.8 | · | 8.3 | 6.6 | 7.2 | · | 4.5 | 2.7 | 2.8 | · | 3.3 | 3.1 | 4.0 | · | 2.8 | |
| P/B | 22.0 | 22.1 | · | 25.2 | 15.9 | 14.2 | · | 9.7 | 6.3 | 6.2 | · | 6.3 | 5.3 | 8.7 | · | 4.8 | |
| P / Tangible Book | 1129.1 | · | · | · | · | · | · | 15.3 | 11.5 | 10.6 | · | 8.4 | 7.2 | 14.7 | · | 8.6 | |
| P / Cash Flow | · | 91.2 | · | · | · | 166.6 | · | · | · | -39.0 | · | · | · | -63.4 | · | · | |
| EV / Revenue | 9.6 | 7.8 | · | 8.2 | 6.6 | · | · | 4.0 | 2.3 | 2.5 | · | 2.6 | 2.4 | 3.5 | · | 2.1 |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $80M | $39M | $32M | $21M | $22M |
| Bruttogewinnmarge % | 53.5% | 60.0% | · | 67.4% | 88.0% |
| Betriebsgewinnmarge % | -1.1% | -6.7% | · | -38.9% | -6.9% |
| Nettoergebnis | $-5M | $-4M | $-936.0K | $-9M | $-2M |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 1.2 | 0.0 | · | 0.1 | 0.1 |
| Liquiditätsgrad | 1.6 | 2.1 | · | 3.1 | 5.2 |
| Quick Ratio | 1.0 | 1.0 | · | 2.8 | 4.4 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $10M | $943.0K | · | $5M | $-5M |
Institutionelle Eigentümer (13F) 172 Einreicher · $736.8M gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
172
Gehaltener Wert
$736.8M
Neue Positionen
53
Geschlossene Positionen
5
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 53 (+18 vs. Vorquartal) | 5 (-10 vs. Vorquartal) | 59 (+23 vs. Vorquartal) | 38 (+6 vs. Vorquartal) | +2.1M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Opaleye Management Inc. | $103.532.000 | 2.860.000 | 14,05% | Aktien |
| EcoR1 Capital, LLC | $78.624.156 | 2.171.938 | 10,67% | Aktien |
| BlackRock, Inc. | $68.629.156 | 1.895.833 | 9,31% | Aktien |
| Nantahala Capital Management, LLC | $42.569.426 | 1.175.951 | 5,78% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $35.351.834 | 976.570 | 4,80% | Aktien |
| MORGAN STANLEY | $27.800.585 | 767.972 | 3,77% | Aktien |
| STATE STREET CORP | $25.404.653 | 701.786 | 3,45% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $23.618.970 | 652.303 | 3,21% | Aktien |
| VANGUARD GROUP INC | $22.805.976 | 1.348.668 | 3,10% | Aktien |
| OBERWEIS ASSET MANAGEMENT INC/ | $18.157.920 | 501.600 | 2,46% | Aktien |
| National Philanthropic Trust | $17.814.454 | 492.112 | 2,42% | Aktien |
| Westside Investment Management, Inc. | $15.608.010 | 431.160 | 2,12% | Aktien |
| Pillsbury Lake Capital LLC | $14.015.083 | 387.157 | 1,90% | Aktien |
| Nuveen, LLC | $13.600.593 | 375.707 | 1,85% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $11.673.269 | 322.466 | 1,58% | Aktien |
| Woodline Partners LP | $11.253.820 | 310.879 | 1,53% | Aktien |
| NORTHERN TRUST CORP | $9.261.733 | 255.849 | 1,26% | Aktien |
| MARSHALL WACE, LLP | $9.020.387 | 249.182 | 1,22% | Aktien |
| Panoramic Capital, LLC | $7.536.550 | 208.192 | 1,02% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $7.044.194 | 194.591 | 0,96% | Aktien |
| JPMORGAN CHASE & CO | $7.038.753 | 191.635 | 0,96% | Aktien |
| D. E. Shaw & Co., Inc. | $6.821.962 | 188.452 | 0,93% | Aktien |
| JANE STREET GROUP, LLC | $6.722.232 | 185.697 | 0,91% | Aktien |
| Lumbard & Kellner, LLC | $6.367.906 | 175.909 | 0,86% | Aktien |
| CANNELL CAPITAL LLC | $6.181.041 | 170.747 | 0,84% | Aktien |
| NORGES BANK | $6.135.900 | 169.500 | 0,83% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $6.101.112 | 168.539 | 0,83% | Aktien |
| Informed Momentum Co LLC | $5.721.229 | 158.045 | 0,78% | Aktien |
| Prospect Capital Advisors, LLC | $5.690.640 | 157.200 | 0,77% | Aktien |
| Aristides Capital LLC | $5.263.842 | 145.410 | 0,71% | Aktien |
| BANK OF AMERICA CORP /DE/ | $5.149.704 | 142.257 | 0,70% | Aktien |
| PRELUDE CAPITAL MANAGEMENT, LLC | $4.980.106 | 137.572 | 0,68% | Aktien |
| GOLDMAN SACHS GROUP INC | $4.799.505 | 132.583 | 0,65% | Aktien |
| Bank of New York Mellon Corp | $4.280.614 | 118.249 | 0,58% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $4.209.734 | 116.291 | 0,57% | Aktien |
| WELLS FARGO & COMPANY/MN | $4.150.510 | 114.655 | 0,56% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3.232.660 | 89.300 | 0,44% | Kaufoption |
| Bridge City Capital, LLC | $3.190.378 | 88.132 | 0,43% | Aktien |
| Walleye Capital LLC | $3.122.214 | 86.249 | 0,42% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2.788.558 | 77.032 | 0,38% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $2.754.928 | 76.103 | 0,37% | Aktien |
| Diametric Capital, LP | $2.646.256 | 73.101 | 0,36% | Aktien |
| Numerai GP LLC | $2.538.127 | 70.114 | 0,34% | Aktien |
| UBS Group AG | $2.368.349 | 65.424 | 0,32% | Aktien |
| Squarepoint Ops LLC | $2.156.144 | 59.562 | 0,29% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $2.082.079 | 57.516 | 0,28% | Aktien |
| BARCLAYS PLC | $2.033.751 | 56.181 | 0,28% | Aktien |
| HighTower Advisors, LLC | $1.915.233 | 52.907 | 0,26% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $1.893.260 | 52.300 | 0,26% | Aktien |
| CITADEL ADVISORS LLC | $1.772.678 | 48.969 | 0,24% | Aktien |
Aktivisten & 5%+-Eigentümer 3 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Harrow, Inc. | 30. April 2024 | · | Erste Einreichung | · | SEC |
| 28. Januar 2022 | · | Erste Einreichung | · | SEC | |
| Imprimis Pharmaceuticals, Inc. 2) | 23. November 2018 | · | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 13 Insider · 6 Führungskräfte · 6 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Sean Brynjelsen | President & CEO | 20. August 2026 S | 961.194 | 0 | 6 | $-9.913.490 |
| Judith M. Matthews | Chief Financial Officer | 31. Juli 2026 A | · | 0 | 0 | $0 |
| James R. Gruber | Chief Financial Officer | 12. Januar 2026 A | 213.420 | 0 | 0 | $0 |
| William Wilson Troutman | CFO and Secretary | 7. Februar 2022 A | 23.027 | 0 | 0 | $0 |
| David Krempa | Chief Business Officer | 24. August 2026 M | 37.025 | 0 | 6 | $-4.856.467 |
| Ipek Erdogan-Trinkaus | Chief Commercial Officer | 31. Juli 2026 A | 2.403 | 0 | 0 | $0 |
| Paul V Maier | Direktor | 28. August 2026 M | 72.245 | 0 | 6 | $-5.907.146 |
| Jennifer Mckie Adams | Direktor | 31. Juli 2026 A | 0 | 0 | 1 | $-1.624.000 |
| Norbert G Riedel | Direktor | 31. Juli 2026 A | 67.155 | 0 | 0 | $0 |
| Charles J Casamento | Direktor | 31. Juli 2026 A | 71.920 | 0 | 0 | $0 |
| Mark L. Baum | Direktor | 12. März 2020 A | 10.000 | 0 | 0 | $0 |
| Opaleye Management Inc. | 10%-Eigentümer | 14. Juli 2026 S | 40.000 | 0 | 9 | $-6.894.893 |
| Imprimis Pharmaceuticals, Inc. | 10%-Eigentümer | 12. April 2021 S | 1.982.000 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 23 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 1,25% | 5.548 NS | 31. Juli 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 1,03% | 56.840 SH | 2. Oktober 2026 | Täglich |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,42% | 32.552 SH | 2. Oktober 2026 | Täglich |
| IWC · iShares Trust | 0,36% | 90.559 SH | 11. September 2026 | Täglich |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,34% | 17.526 SH | 2. Oktober 2026 | Täglich |
| IWO · iShares Trust | 0,10% | 251.522 SH | 11. September 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,10% | 2.033 SH | 2. Oktober 2026 | Täglich |
| VFQY · VANGUARD WELLINGTON FUND | 0,08% | 9.946 SH | 19. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,06% | 28.627 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,05% | 685.344 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,04% | 12.766 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 153.798 SH | 19. August 2026 | Täglich |
| WSML · iShares Trust | 0,01% | 1.473 SH | 11. September 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 271.003 SH | 19. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,00% | 16.216 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 9.210 SH | 11. September 2026 | Täglich |
| ITOT · iShares Trust | 0,00% | 39.879 SH | 11. September 2026 | Täglich |
| DFSU · Dimensional ETF Trust | 0,00% | 998 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 1.223 NS | 31. Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 1.723 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 1.005 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 684.821 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.220 SH | 19. August 2026 | Täglich |
ETON Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 10 Analysten
KAUF
Median-Ziel
$70.00
+26,4%
2 20,0%
Starker Kauf
7 70,0%
Kauf
1 10,0%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
4 Analysten · 2026-10-04Mittelwert-Ziel $71.00 +28,3%
← Unter allen Zielen
Aktueller Preis $55.36
Tief$68.00
Mittelwert$71.00
Hoch$76.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ETON | $457M | · | 104.9% | -5.8% | -18.4% | 53.5% |
| SEPN | $1.25B | -25.3 | 4174.5% | -106.4% | -12.9% | · |
| ANIP | $1.78B | 23.8 | 43.8% | 8.9% | 16.6% | · |
| OCUL | $2.62B | -8.5 | -18.5% | -511.9% | -55.4% | · |
| RAPP | $1.45B | -10.6 | · | · | -29.8% | · |
| PAHC | · | 12.9 | 17.1% | 6.6% | 29.7% | 33.8% |
| NKTR | $862M | -4.3 | -43.9% | -297.1% | -500.1% | · |
| MAZE | $2.04B | -13.6 | · | · | -598.9% | · |
| INVA | · | 6.1 | 14.7% | · | · | · |
| XERS | $1.30B | · | 43.7% | 0.19% | -19.7% | · |
| KARD | · | · | · | · | · | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
H.C. Wainwright bleibt optimistisch für die Wachstumsstrategie von Eton Pharmaceuticals (ETON)
Yahoo Finance · 4 Monate, 1 Woche vor
Eton Pharmaceuticals (ETON) Appointed Judith M. Matthews as New CFO
Yahoo Finance · 5 Monate, 1 Woche vor
Eton Pharmaceuticals Bestimmt Judith Matthews zur CFO, Wirksam ab Juni
Nasdaq · 5 Monate, 2 Wochen vor
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 13, 2026